Broker-Dealer AgreementBroker-Dealer Agreement • January 19th, 2023 • Algernon Neuroscience Inc. • Pharmaceutical preparations
This agreement (together with exhibits and schedules, the “Agreement”) is entered into by and between Algernon Neuroscience Inc (“Client”), a British Columbia Corporation, and Dalmore Group, LLC., a New York Limited Liability Company (“Dalmore”). Client and Dalmore agree to be bound by the terms of this Agreement, effective as of December 9, 2022 (the “Effective Date”):
